News Notification

Cleveland Clinic Cardiovascular Update 2025

74 views Tags: CME Cleveland Clinic Center

Best practices for cardiovascular disease prevention, care & outcomes

Cleveland Clinic Cardiovascular Update incorporates the latest science and clinical best practices to improve cardiovascular disease prevention, care and outcomes.  A world class faculty delivers essential educational content emphasizing cutting edge advances, the implementation of evidence-based guidelines and the promotion of health equity among diverse populations.  Application of the lessons discussed throughout this activity should result in improved cardiovascular outcomes for patients.

* Date of Original Release: 15/01/2025

LEARNING OBJECTIVES

Upon completion of this activity, the participant will be able to:

  • Reduce cardiovascular risks through optimal management of dyslipidemia, hypertension, diabetes and obesity.
  • Address the issues associated with primary prevention therapy in specific populations including women and the elderly.
  • Describe innovations in diagnostic modalities and their clinical use to screen, diagnose and treat patients with cardiovascular disease.
  • Apply recent evidence on mitral regurgitation, cardiac murmurs and aortic stenosis into clinical decision making for patients with structural heart disease.
  • Employ evidence-based therapies and consensus guidelines for the diagnosis, evaluation and management across the entire spectrum of patients with heart failure and cardiomyopathy.
  • Utilize current evidence and guideline recommendations to detect and manage patients with cardiac arrhythmias.

CLEVELAND CLINIC CARDIOVASCULAR UPDATE 2025

0 0 votes
Article Rating

CLEVELAND CLINIC CARDIOVASCULAR UPDATE 2025 TOPICS

1. Tools in CVD Prevention and Risk Management: To Test or Not to Test? Lp(a), apoB, Non HDL-C – Dennis Bruemmer, MD, PhD

2. Statin Initiation for Primary Prevention Among Statin Naïve Adults and Reasons for Nonadherence – Vikas Sunder, MD

3. When Statins Are Not Enough – Non-statin Lipid Lowering Therapies to Manage Residual Risk – Ashish Sarraju, MD

4. Managing Anti-Hyperglycemic and CV Risk Reduction Agents in Patients With Diabetes: SGLT2i or GLP1RA or Both? – Dennis Bruemmer, MD, PhD

5. Weight Loss Pharmacotherapy: Utilizing Current Therapies and Exploring the Next Generation of Weight Loss Medications – Steve Nissen, MD

6. Keto, Low Carb, Plant Based, IF: Controversies in the Evidence for the “Best“ Diet – Julia Zumpano, RD, LD

7. Old and Evolving Strategies for Treatment-Resistant Hypertension – Luke Laffin, MD

8. Social Determinants of Health and Cardiovascular Disease: Current State and Future Directions – Lee Kirksey, MD

1. Hormone Therapy and Heart Health: Debunking Myths, Embracing Evidence – Luke Laffin, MD

2. The Intersection of Cardiovascular Disease and Chronic Kidney Disease – Crystal Gadegbeku, MD

3. Who Should Get a CAC? How Often? How to Use the Results to Assess Risk? – Milind Desai, MD

4. Management of CV Issues in the Elderly: Geriatric Cardiology – Ardeshir Hashmi, MD

5. Population Health Management: Interventions to Control Cardiovascular Disease Risk Factors – LeRoi Hicks, MD

1. Cardiac Disease Remains the Leading Cause of Mortality in Women – Vikas Sunder, MD

2. Cardiovascular Disease and Pregnancy: Optimizing Maternal and Fetal Health – Deirdre Mattina, MD

3. Competitive Sports Participation in Athletes with Heart Disease – Tamanna Singh, MD

4. Cardio-oncology: Optimizing the Balance Between Cancer Outcomes and Cardiac Success – Patrick Collier, MD, PhD

1. Role of Advanced Imaging for Ischemic Heart Disease – Saberio Lo Presti Vega, MD

2. Creating a Pathway for the Management of Stable Angina in Your Clinic – Ben Alencherry, MD

3. ANOCA, INOCA, MINOCA: What Does It All Mean? – Khalid Ziada, MD

4. How Do I Manage my Post MI Patient (Including DAPT Guidelines/Duration/Cardiac Rehab) – Venu Menon, MD

5. Cardiac Rehab: Why it is Critical and How Can We Improve Access and Compliance? – Erik Van Iterson, PhD, MS

6. Peripheral Artery Disease: Assessment and Clinical Decision Making – Lee Kirksey, MD

1. Aortic Stenosis: Diagnosis and Management in the Modern Era – Samir Kapadia, MD

2. MR: How to Diagnose and Manage Mitral Valve Disease – L. Leonardo Rodriguez, MD

3. Natural History of Tricuspid Regurgitation: Current and Future Management – Amar Krishnaswamy, MD

4. Bicuspid and Aneurysm-Associated Aortic Valve Disease – Milind Desai, MD

5. Guidelines for Anticoagulation Following Structural Heart Therapies – Grant Reed, MD, MSc

6. Hypertrophic Cardiomyopathy: Co-management in the Era of Emerging Precision Therapies – Milind Desai, MD

1. Heart Failure Stages, Phenotypes and Diagnosis – Randall Starling, MD

2. HFrEF: Essentials of Guideline Directed Medical Therapy – Amanda Vest, MBBS

3. Managing Comorbidities in HF – Frailty, Anemia, Sleep Apnea, AF, Obesity – Karlee Hoffman, DO

4. Essentials of Diagnosis and Management for HFpEF – Sanjeeb Bhattacharya, MD

5. Diagnosis and Management of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) – Mazen Hanna, MD

6. Strategies to Enhance GDMT Implementation and Adherence – M. Trejeeve Martyn, MD

7. Managing Long Term LVADs and Transplant Recipients – Ike Okwuosa, MD

8. Collaboration Between EP and HF: CRT and Novel Pacing – Niraj Varma, MD, PhD

1. Diagnosis and Management of New-Onset Atrial Fibrillation – Mohamed Kanj, MD

2. AF and Left Atrial Appendage Closure: Current and Future Directions – Mohamed Kanj, MD

3. What I Need to Know to Evaluate and Manage the Patient With PVCs and SVT – Pasquale Santangeli, MD, PhD

4. Evaluation and Management of Syncope in the Young Adult – Kenneth Mayuga, MD

5. Follow-Up of Pacemakers and ICDs For the Non-Electrophysiologist – Kevin F. Kwaku, MD, PhD

6. Wearables for Arrhythmia Care: Current Challenges and Future Prospects – Niraj Varma, MD, PhD

Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
error: Content is protected !!